IVERTIKULYaRNAYa BOLEZN' TOLSTOY KIShKI: PODKhODY K LEChENIYu


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Diverticular disease is the most common organic pathology of the colon in patients older than 60 years. Uncomplicated (i.e. without endoscopic signs of inflammation) diverticular disease in 20-35 % of patients occurs with severe pain, flatulence and/or impaired stool that leads to reduction of quality of life of patients and requires prescribing of drugs of various pharmacological groups in addition to dietary recommendations. Standard therapy with antispasmodics is not always high effective, because patients with diverticular disease of the colon represent heterogeneous group. This requires an individual approach to the treatment. The article discusses the various groups of drugs and the potentials for their application depending on the predominance of certain symptoms.

Full Text

Restricted Access

About the authors

S. V Levchenko

Email: sv_levchenko@list.ru

References

  1. Delvaux M. Diverticular disease of the colon in Europe: epidemiology, impact on citizen health and prevention. Aliment Pharmacol Ther. 2003; 18(Suppl. 3): 71-4.
  2. Lazebnik L., Baryshnikov E., Parfenov A., Prilepskaja S., et al. First results of epidemiological study MUZe (prevalence of colon diverticulosis, colorectal polips and colorectal cancer among adult population of Moscow with chronic constipation and alarm symptoms). Scandinavian J. Gastroent. 2010; 45(Suppl. 247): 86.
  3. Stollman N.H., Morgan R., et al. Hospitalizations for diverticular disease. Effects of age on presentation. Am. J. Gastroenterol. 1999; 11: 3110-21.
  4. Воробьев Г.И. (ред.) Основы колопроктологии. М., 2006. 432 с.
  5. Filik L., Biyikoglu I. Colonic angiodysplasia and diverticula: a single-institution experience. Histopathology.2010; 57(6): 395.
  6. Broderick-Villa G., Burchette R.J., Collins J.C., Abbas M.A., Haigh P.I. Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch. Surg. 2005; 140: 576-81.
  7. Практическая гериатрия (избранные клинические и организационные аспекты) / Под ред. Л.Б. Лазебника. М., 2002. 555 с.
  8. Kang J.Y., Firwana B., Green A.E., et al. Uncomplicated diverticular disease is not a common cause of colonic symptoms. Aliment. Pham. Ther. 2011; 33(4): 487-94.
  9. Commane D.M., Arasaradnam R.P., Mills S., et al. Diet, ageing and genetic factors in the pathogenesis of diverticular disease, World J. Gastroenterol. 2009; 15(20): 2479-88.
  10. Petruzziello L., lacopini F., et al., Review article: uncomplicated diverticular disease of the colon. Aliment. Pharmacol. Ther. 2006; 23: 1379-91.
  11. Loffeld R.J. Diverticulosis of the colon is rare amongst immigrants living in the Zaanstreek region in the Netherlands. Colorectal Dis. 2005; 7(lssue 6): 559-62.
  12. Aldoori W.H., Giovannucci E.L., Rockett H.R., et al. A prospective study of dietary fiber types and symptomatic diverticular disease in men. J. Nutr. 1998; 128: 714-19.
  13. Blashut K., Paradowski L., Garcarek J. Prevalence and distribution of the colonic diverticulosis. Review of 417 cases from Lower Silesia in Poland. Rom. J. Gastroenterol. 2004; 13(4): 281-85.
  14. Painter N.S., Burkitt D.P. Diverticular disease of the colon: A deficiency disease of western civilization. Br. Med. J. 1971; 2: 450-54.
  15. Manousos O., Day N.E., Tzonou А., et al. Diet and other factors in the etiology of diverticulosis: an epidemiological study in Greece. Gut. 1985; 26(6): 544-49.
  16. Парфенов А.И. Энтерология. М., 2009. 875 с.
  17. Moreyra A.E., Wilson A.C., Koraym A. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch. Intern. Med. 2005; 165(10): 1161-66.
  18. Uehleke B., Ortiz M., Stange R. Cholesterol reduction using psyllium husks - do gastrointestinal adverse effects limit compliance? Results of a specific observational study. Phytomedicine. 2008; 15(3): 153-59.
  19. Dobbins C., Defontgalland D., Duthie G., Wattchow D.A. The relationship of obesity to the complications of diverticular disease.Colorectal Dis. 2006; 8(1): 37-40.
  20. Jeong J.H., Lee H.L., et al. Correlation between complicated diverticulitis and visceral fat. J. Korean Med. Sci. 2011; 26(10): 1339-43.
  21. Strate L.L., Liu Y.L., Aldoori W.H., et al. Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterol. 2009; 136(1); 115-22.
  22. Kopylov U., Ben-Horin S., Lahat A., Segev S. Obesity, metabolic syndrome and the risk of development of colonic diverticulosis, Digestion. 2012; 86(3): 201-05.
  23. Korzenik J.R. Diverticulitis: new frontiers for an old country: risk factors and pathogenesis. NDSG. J. Clin. Gastroenterol. 2008; 42(10): 1128-29.
  24. Strate L.L., Liu Y.L., Aldoori W.H. et al. Physical activity decreases diverticular complications. Am. J. Gastroenterol. 2009; 104(5): 1221-30.
  25. Ballinger A. Adverse effects of non-steroidal anti-inflammatory drugs on the colon. Curr. Gastroentrol. Rep. 2008; 10(5): 485-89.
  26. Lamps L.W., Knapple W.L. Diverticular disease-associated segmental colitis. Clin. Gastroenterol. Hepatol. 2007; 5: 27-31.
  27. Головенко О.В., Халиф И.Л., Головенко А.О. Роль масляной кислоты и инулина в лечении органических и функциональных заболеваний кишечника. Пособие для врачей. М., 2012. 40 с.
  28. Левченко С.В., Лазебник Л.Б., Потапова В.Б., Рогозина В.А. Клинико-морфологические варианты дивертикулярной болезни толстой кишки. Экспериментальная и клиническая гастроэнтерология. 2013; 3: 24-31.
  29. Яковенко Э.П., Яковенко А.В., Агафонова Н.А. и др. Абдоминальные боли: Механизмы формирования, рациональный подход к выбору терапии. РМЖ. 2009; 11(2): 48-53.
  30. Лазебник Л.Б., Дроздов В.Н. Заболевания органов пищеварения у пожилых, Анахарсис, 2003. 208 с.
  31. Mehmood M.H., Aziz N., Ghayur M.N., Gilani A.H. Pharmacological basis for the medicinal use of psyllium husk (Ispaghula) in constipation and diarrhea. Dig. Dis. Sci. 2011; 56(5): 1460-71.
  32. Попова Е.В. Нарушение состава кишечной микрофлоры в механизмах формирования клинико-морфологических проявлений у больных дивертикулярной болезнью толстой кишки. Дисс.. канд. мед. наук. 2012. 121 с.
  33. Бондаренко В.М. Роль условно-патогенных бактерий при хронических процессах различной локазизации. М., 2011. 88 с.
  34. Радченко В.Г., Добрица В.П., Селиверстов П.В., Тетерина Л.А., Чихачева Е.А. Актуальные вопросы коррекции микробиоценоза кишечника. Учебно-методическое пособие. СПб., 2012. 30 с.
  35. Bogardus Jr., Sidney T. What Do We Know About Diverticular Disease? J. Clin. Gastroenterol. 2006; 40: S108-11.
  36. de Korte N., Unlu C., Boermeester M.A., et al. (June 2011). Use of antibiotics in uncomplicated diverticulitis. Br J Surg 98(6): 761-67. doi: 10.1002/bjs.7376. PMID: 21523694.
  37. Tursi A., Brandimarte G., Giorgetti G.M., et al. Mesalazine and/or lactobacillus cases in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: A prospective, randomized, open-label study. J. Clin. Gastroenterol. 2006; 40: 312-16.
  38. Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis (NCT00695643). 2009. Available from: URL: http://www.clinicaltrials.gov/ct2/show/NCT00695643
  39. Di Mario F., Comparato G., Fanigliulo L., et al. Use of mesalazine in diverticular disease. J. Clin. Gastroenterol. 2006; 40(Suppl. 3): S155-59.
  40. Gatta L., Vakil N., Vaira D., et al. Efficacy of 5-ASA in the treatment of colonic diverticular disease. J. Clin. Gastroenterol. 2010; 44(2): 113-19.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies